Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Deflazacort. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 known ✓ | P04150 | 9/20 | 0.84 |
| ▸ | PGR | P06401 | 8/20 | 0.84 |
| ▸ | HIF1A | Q16665 | 6/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.67 |
| ▸ | AR | P10275 | 4/20 | 0.67 |
| ▸ | ABCB11 | O95342 | 3/20 | 0.67 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.67 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.67 |
| ▸ | TNF | P01375 | 1/20 | 0.67 |
| ▸ | IL6 | P05231 | 1/20 | 0.67 |
| ▸ | GLUL | P15104 | 1/20 | 0.67 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.67 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | F2 | P00734 | 1/20 | 0.56 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Deflazacort SCHEMBL4019 | 0.92 | NR3C1 (1.00) | NR3C1PGRHIF1ACYP3A4HSD17B10 | |
| Deflazacort SCHEMBL24497637 | 0.92 | NR3C1 (1.00) | NR3C1PGRHIF1ACYP3A4HSD17B10 | |
| Deflazacort SCHEMBL2598076 | 0.92 | NR3C1 (1.00) | NR3C1PGRHIF1ACYP3A4HSD17B10 | |
| Deflazacort SCHEMBL4018 | 0.92 | NR3C1 (1.00) | NR3C1PGRHIF1ACYP3A4HSD17B10 | |
| Deflazacort SCHEMBL4259541 | 0.91 | NR3C1 (0.95) | NR3C1PGRHIF1ACYP3A4HSD17B10 | |
| Deflazacort SCHEMBL22502722 | 0.91 | NR3C1 (0.98) | NR3C1PGRHIF1ACYP3A4HSD17B10 | |
| Deflazacort SCHEMBL17941674 | 0.89 | NR3C1 (0.94) | NR3C1PGRHIF1ACYP3A4HSD17B10 | |
| Prednisolone Acetate SCHEMBL9806568 | 0.87 | HIF1A (0.93) | NR3C1PGRHIF1ACYP3A4HSD17B10 | |
| Prednisolone Acetate SCHEMBL9806574 | 0.87 | HIF1A (0.93) | NR3C1PGRHIF1ACYP3A4HSD17B10 | |
| 21-Desacetyldeflazacort SCHEMBL30754690 | 0.87 | NR3C1 (0.81) | NR3C1PGRHIF1ACYP3A4HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011146819-A2 | METHODS AND COMPOSITIONS FOR TREATMENT NF-κB-MEDIATED AND α7 INTEGRIN-SUPPRESSED DISEASES | DMD THERAPIES, LLC (US) | 2011-11-24 | — | — | WO | disclosed |
| US-20110217715-A1 | GENE EXPRESSION IN DUCHENNE MUSCULAR DYSTROPHY | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2011-09-08 | — | — | US | disclosed |
| EP-2344670-A1 | GENE EXPRESSION IN DUCHENNE MUSCULAR DYSTROPHY | Children's Hospital Medical Center (US) | 2011-07-20 | — | — | EP | disclosed |
| US-20100105054-A1 | GENE EXPRESSION IN DUCHENNE MUSCULAR DYSTROPHY | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2010-04-29 | — | — | US | disclosed |
| WO-2010045405-A1 | GENE EXPRESSION IN DUCHENNE MUSCULAR DYSTROPHY | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2010-04-22 | — | — | WO | disclosed |